Page last updated: 2024-12-06
3-amino-1-phenylbutane
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
3-amino-1-phenylbutane: urinary metabolite of labetalol; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 31160 |
SCHEMBL ID | 1280 |
MeSH ID | M0162115 |
Synonyms (66)
Synonym |
---|
nsc 115524 |
benzenepropanamine, alpha-methyl- |
1-phenyl-3-amino-butan [german] |
brn 2413110 |
propylamine, alpha-methyl-gamma-phenyl- |
einecs 244-942-2 |
alpha-methyl-gamma-phenyl-n-propylamin [german] |
alpha-methyl-gamma-phenyl-n-propylamine |
alpha-methylbenzenepropanamine |
4-phenyl-2-aminobutane |
nsc115524 |
.alpha.-methylbenzenepropanamine |
benzenepropanamine, .alpha.-methyl- |
nsc-115524 |
1-methyl-3-phenylpropylamine |
propylamine, 1-methyl-3-phenyl- |
1-phenyl-3-aminobutane |
3-amino-1-phenylbutane |
22374-89-6 |
1-methyl-3-phenylpropylamine, 98% |
4-phenyl-2-butylamine |
A0999 |
22148-77-2 |
wecuigdewbnqjj-uhfffaoysa- |
inchi=1/c10h15n/c1-9(11)7-8-10-5-3-2-4-6-10/h2-6,9h,7-8,11h2,1h3 |
4-phenylbutan-2-amine |
AKOS000119752 |
2-amino-4-phenylbutane |
A815973 |
[(1s)-1-methyl-3-phenyl-propyl]ammonium |
A816167 |
unii-326655w66z |
alpha-methyl-gamma-phenyl-n-propylamin |
1-phenyl-3-amino-butan |
326655w66z , |
FT-0608062 |
FT-0605036 |
FT-0605241 |
FT-0604461 |
PS-5334 |
1-methy-3-phenylpropylamine |
1-phenyl-3-butylamine |
1-methyl-3-phenyl-propylamine |
1-methyl 3-phenyl-propylamine |
AKOS016051338 |
SCHEMBL1280 |
W-107477 |
3-phenyl-1-methylpropylamine |
propylamine, .alpha.-methyl-.gamma.-phenyl- |
.alpha.-methyl-.gamma.-phenyl-n-propylamine |
4-phenyl-2-butanamine |
(3-aminobutyl)benzene |
F2190-0401 |
mfcd00008090 |
AC-8354 |
(r)-alpha-methylbenzenepropanamine |
DTXSID60871334 |
STL193993 |
AMY40882 |
Q27256149 |
benzenepropanamine, -methyl- |
SB47247 |
methyl-(3-phenylpropyl)- |
CS-0022291 |
EN300-20027 |
Z104476462 |
Research Excerpts
Pharmacokinetics
Excerpt | Reference | Relevance |
---|---|---|
" Pharmacokinetic analysis shows the apparent elimination half-life of the metabolite to be 13." | ( Disposition, metabolism, and pharmacodynamics of labetalol in adult sheep. Abbott, FS; Axelson, JE; Doroudian, A; Hall, C; Kwan, E; Rurak, DW; Yeleswaram, K, ) | 0.13 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (3)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 25.19
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.19) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (20.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |